Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
The most recent EPS for Aurora Cannabis Inc. is $0.03, not beating expectations of $0.21.
How did Aurora Cannabis Inc. ACB's revenue perform in the last quarter?
Aurora Cannabis Inc. revenue for the last quarter is $0.03
What is the revenue estimate for Aurora Cannabis Inc.?
According to 6 of Wall street analyst, the revenue estimate of Aurora Cannabis Inc. range from $85.26M to $65.66M
What's the earning quality score for Aurora Cannabis Inc.?
Aurora Cannabis Inc. has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Aurora Cannabis Inc. report earnings?
Aurora Cannabis Inc. next earnings report is expected in 2026-05-05
What are Aurora Cannabis Inc.'s expected earnings?
Aurora Cannabis Inc. expected earnings is $93.29M, according to wall-street analysts.
Did Aurora Cannabis Inc. beat earnings expectations?
Aurora Cannabis Inc. recent earnings of $94.19M beat expectations.